The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Stefan Blochlinger

Showing 1-2 of 2 articles
Coronary interventions
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabaté M, Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12

Latest news

NEW ISSUE
The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...
December 18, 2020
NEW
Elective Cardiac Invasive Procedures during the COVID-19 Outbreak
A. Chieffo et al.
January 8, 2021
Editorial
Addressing interventional periprocedural anxiety with virtual reality
Nico Bruining
January 13, 2021
Trials Book
SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS
(Thanks to the support of Biotronik)
January 13, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Translating ISCHEMIA into practice
William E. Boden
January 13, 2021
JAA
This Week's JAA's: BIOFREEDOM-QCA trial, TTVr with the TriClip/MitraClip G4 System, Numerical prediction of coronary artery compression in TPVI...
January 12, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke